A different study from 2021 by Pervaiz et al. [40] explored the therapeutic potential of CCR5 inhibition in colorectal cancer (CRC) with liver metastasis, using both siRNAs and the CCR5 antagonist maraviroc. Here, CCR5 is linked to colorectal carcinoma.